https://www.bloomedi.com/ko/media/breast/china-expands-liporaxel-approval-to-her2-negative-breast-cancer-194053 MediIndex ko 2026-10-08T14:34:43.152Z 중국, 리포락셀액 HER2 음성 유방암 적응증 추가 승인 https://www.bloomedi.com/en/media/breast/china-expands-liporaxel-approval-to-her2-negative-breast-cancer-194053 MediIndex en 2026-10-08T14:34:43.152Z China Expands Liporaxel Approval to HER2-Negative Breast Cancer https://www.bloomedi.com/ko/media/skin/team-develops-skin-tone-conversion-ai-for-skin-diagnosis-c46f34 MediIndex ko 2026-10-08T04:37:07.890Z 서울아산병원 연구팀, 피부질환 진단용 피부색 변환 AI 개발 https://www.bloomedi.com/en/media/skin/team-develops-skin-tone-conversion-ai-for-skin-diagnosis-c46f34 MediIndex en 2026-10-08T04:37:07.890Z Team Develops Skin-Tone Conversion AI for Skin Diagnosis https://www.bloomedi.com/ko/media/skin/foreign-skin-and-plastic-surgery-visits-rose-82-5-in-korea-750a23 MediIndex ko 2026-10-08T04:36:38.395Z 한국 피부·성형외과 외국인 환자 154만명, 전년보다 82.5% 증가 https://www.bloomedi.com/en/media/skin/foreign-skin-and-plastic-surgery-visits-rose-82-5-in-korea-750a23 MediIndex en 2026-10-08T04:36:38.395Z Foreign Skin and Plastic Surgery Visits Rose 82.5% in Korea